Emron Managed Care News 5-22-15

Combination Treatment for Cystic Fibrosis Shows Promise Combining two medications that target the most common genetic cause of cystic fibrosis improved lung function in people with the disease. The combination therapy also reduced the rate of lung infections and other problems, according to a new study. Prostate Cancer Testing Drops Off After Controversial Guidelines Fewer … Continued

Emron Managed Care News 5-15-15

Emron Managed Care News Blood Thinner Warfarin May Pose Greater Bleeding Risk for Obese: Study Obese patients taking the blood thinner warfarin appear to have almost twice the risk of severe stomach bleeding compared to their normal-weight counterparts, a new study suggests. Medicaid Expansion Is Still A Tumultuous Fight In Several States Five years after the Affordable Care Act passed, … Continued

Emron Managed Care News 5-8-15

FDA clears The Medicines Company’s Raplixa, Ionsys The FDA approved The Medicines Company’s Raplixa (fibrin sealant) as the first spray-dried fibrin sealant cleared in the US to help control bleeding during surgery, the company announced. The biological product is approved for use in adults to help control bleeding from small blood vessels when standard surgical … Continued